<?xml version="1.0" encoding="UTF-8"?>
<ref id="B25-pharmaceuticals-12-00101">
 <label>25.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Chambers</surname>
    <given-names>T.J.</given-names>
   </name>
   <name>
    <surname>Weir</surname>
    <given-names>R.C.</given-names>
   </name>
   <name>
    <surname>Grakoui</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>McCourt</surname>
    <given-names>D.W.</given-names>
   </name>
   <name>
    <surname>Bazan</surname>
    <given-names>J.F.</given-names>
   </name>
   <name>
    <surname>Fletterick</surname>
    <given-names>R.J.</given-names>
   </name>
   <name>
    <surname>Rice</surname>
    <given-names>C.M.</given-names>
   </name>
  </person-group>
  <article-title>Evidence that the N-terminal domain of nonstructural protein NS3 from yellow fever virus is a serine protease responsible for site-specific cleavages in the viral polyprotein</article-title>
  <source>Proc. Natl. Acad. Sci. USA</source>
  <year>1990</year>
  <volume>87</volume>
  <fpage>8898</fpage>
  <lpage>8902</lpage>
  <pub-id pub-id-type="doi">10.1073/pnas.87.22.8898</pub-id>
  <?supplied-pmid 2147282?>
  <pub-id pub-id-type="pmid">2147282</pub-id>
 </element-citation>
</ref>
